ROSSARI

What Rossari Biotech promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 21 tracked 2 delivered 2 missed 17 open
  • Core B2B EBITDA Margin delivered, diluted said Q2 FY26 Promised: 14% - 16% Q1 FY27: Core B2B EBITDA margin for Q1 FY27 was reported at 14.0%, continuing the trend of meeting only the absolute low end of the guided range.
  • Institutional Cleaning Sales (FY25) delivered said Q2 FY25 Promised: ₹250 crores Q1 FY27: This promise pertains to a prior fiscal year and is considered closed.
  • Institutional Cleaning Sales (2-Year Target) revised down said Q3 FY25 Promised: Rs. 450 – Rs. 500 crore in 2 years Q1 FY27: Management is actively rationalizing the B2C business, which was part of the institutional segment, making the original target of doubling the business strategically obsolete and unachievable.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 21 tracked commitments for Rossari Biotech — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens